Drugs / Hib-MenAC conjugate vaccine
last change Nov 2002 re-read 2 minutes ago

Hib-MenAC conjugate vaccine

Developed for
haemophilus infectious disease · meningococcal infection
Investigated by
GlaxoSmithKline

Trials 1 · a red edge is where a trial was stopped

2003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 2 NCT00291967 Nov 2002 → ? diphtheria, haemophilus infectious disease, hepatitis B virus infection, meningococcal infection +2 GlaxoSmithKline Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Hib-MenAC conjugate vaccine ClinicalTrials.gov intervention name — accepted as the source's own label NCT00291967